Supplementary Figures S1-12 from Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma
Open Access
- 2 December 2025
- other
- Published by American Association for Cancer Research (AACR)